Pediatric Stroke
Stroke Subtypes
​
-
Arterial Ischemic Infarction (AIS)
-
Cerebral Sinovenous Thrombosis (CSVT)
-
Hemorrhagic stroke (e.g. intracranial hemorrhage)
​
​
Perinatal and Perinatal Stroke (AIS)
​
-
Definition - AIS in a child from birth (28 weeks gestation) – 28 days of age
-
Etiology - Unknown, likely multifactorial
-
85% born at term
-
-
Prevalence -Rate 1/2000-5000 births
-
Presentation:
-
Seizure (neonate)
-
Hemiparesis or early handedness ( at ~ 5 months for presumed perinatal)
-
​
​
Presenting symptoms for pediatric stroke (AIS)
​
-
Hemiparesis (~50%)
-
Seizure (~50%)
-
Speech disturbance (~20%)
High Risk Populations
​
-
Congenital heart disease
-
Sickle cell disease
-
Down’s syndrome
-
Complex medical disorders
-
ECMO/VAD
-
Acute critical illness
-
Neonates
-
Head and neck infections
-
Trauma
​
​
Stroke Mimics
​
-
Hemiplegic migraine
-
Todd’s paralysis
-
Spinal cord disease (e.g. AFM)
-
PRES
-
MTX toxicity
-
Musculoskeletal disorder
-
Conversion disorder
-
ADEM
-
CNS infection
-
CNS neoplasm
Differential diagnosis for hemiparesis:
​
Stroke (AIS)
-
Acute onset (sudden, abrupt)
-
Symptoms localize to a vascular territory (e.g. ipsilateral face, arm, leg)
-
Painless gait disturbance
-
Typically without MS change
-
Low tone, normal of decreased reflexes
​
Musculoskeletal
-
Monoparesis
-
Guarding of the extremity
-
Refusal to walk, pain, agitation
​
ADEM
-
Gradual onset (hours to days)
-
Associated encephalopathy
-
Neurological deficits in varying locations suggesting more than one location of brain involvement
​
Conversion
-
Sensory complains prominent
-
Tone and reflexes normal
​
Hemiplegic migraine
-
Headache or history of migraine
-
History of similar event that resolved
-
Typically strong sensory component
-
Jacksonian onset, (i.e. starts in fingers and travels up arm in a matter of a few minutes)
​
MTX toxicity
-
Onset may be sudden or gradual
-
History of recent MTX (most often IT)
​
Differential diagnosis for new onset seizure
​
Stroke
-
Neonate
-
Persistent weakness of an affected limb after seizure
-
Normal or mildly elevated BP
-
Recent “viral” illness
-
h/o complex medical disease
​
CSVT
-
Associated encephalopathy
-
Progressive headache or visual disturbance
-
h/o aspariginase, OCP, head/neck infection
Encephalitis
-
Encephalopathy
-
Subtle onset or gradual development of focal neurological deficits
-
Fever
Neoplasm
-
+/- gradual onset of deficits
-
History of progressive headaches
​
PRES
-
Associated medical conditions (e.g. Lupus or BMT) or HTN urgency
-
Preceding visual symptoms
-
Encephalopathy present
​​
Neurological Examination
PedNIH Stroke Scale (PedNIH SS)
​
Pediatric Stroke Outcome Measure (PSOM)
​​​
​
Outcomes
​
-
Immediate mortality quoted as high as 10-40%
-
Mortality from stroke itself is very low (add references)
-
High neurologic morbidity
-
Only 37% of ischemic stroke survivors have full recovery
-
~ 40% of children with AIS have moderate-to-severe persistent deficits (add reference)
-
>25% risk of epilepsy as a late complication (add reference)
-
Recurrence: 6-14%
-
Risk is greatest in the first 6 months
-
Increased in the presence of sickle cell disease, vasculopathy and coagulation abnormalities
-
Increased in the presence of multiple risk factors (~40% > 1 risk factor)
-
Mortality rates are 40% for recurrent strokes vs 3% for first AIS
-
References

Diagnosis and Mimics
​
Standardized Exams
​
-
PedsNIHSS. Ichord, Rebecca N., et al. "Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study." Stroke 42.3 (2011): 613-617.
​
-
PSOM. Kitchen, Lisa, et al. "The pediatric stroke outcome measure: a validation and reliability study." Stroke 43.6 (2012): 1602-1608.